In other countries
The same active substances on other registers, the same brand first.
- CardioxaneBrazil · Adium S.A.Same substance
- CARDIOXANE 500 mg POLVO PARA SOLUCION PARA PERFUSIONSpain · 500 mg · polvo para solución para perfusión · Cnx Therapeutics Ireland LimitedSame substance
- SAVENE 20 mg/ml POLVO PARA CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONSpain · 20 mg · polvo y disolvente para concentrado para solución para perfusión · Cnx Therapeutics Ireland LimitedSame substance
- SaveneEuropean Union · CNX Therapeutics Ireland LimitedSame substance
- SaveneCroatiaSame substance
- CardioxaneItaly · Polvere per soluzione per infusione endovenosa · CNX Therapeutics Ireland LimitedSame substance
- SaveneItaly · Soluzione per infusione · CNX Therapeutics Ireland LimitedSame substance
- Cardioxane 500 mg poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · CNX Therapeutics Ireland LimitedSame substance
- Savene 500 mg, poeder en oplosmiddel voor oplossing voor infusieNetherlands · Oplosmiddel voor parenteraal gebruik, Poeder voor oplossing voor injectie · CNX Therapeutics Ireland LimitedSame substance
- e.g. CardioxaneNew Zealand · Inj 500 mgSame substance
- Dexrazoxane HydrochlorideUnited States · 250MG BASE/VIAL, 500MG BASE/VIAL · injectable · MSNSame substance
- TotectUnited States · 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · ClinigenSame substance
- ZinecardUnited States · 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · PfizerSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Dexrazoxane
- Strength
- 250 MG / VIAL
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 21 May 2026
- Registration
- DIN 02557649
- Marketing authorisation holder
- Hikma Canada Limited
- ATC code
- V03AF02
- Group
- Various
- Supply
- PRESCRIPTION